Skip to content
Parakho

Entero Healthcare Solutions Ltd

NSE ENTEROBSE 544122enterohealthcare.com

Q1 FY27, unaudited

Revenue
₹1,940.50 Cr
Profit after tax
₹52.05 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations1,940.50+38.23%6,591.21
Other income3.01−48.38%19.24
Total income1,943.50+37.87%6,610.45
Employee benefit expense69.42+20.60%245.50
Finance costs20.57+92.91%54.39
Depreciation & amortisation12.31+38.74%43.29
Total expenses1,876.38+36.63%6,422.94
Profit before tax67.12+84.58%179.34
Tax expense15.07+145.78%33.50
Profit after tax52.05+72.17%145.84
Total comprehensive income51.92+71.05%145.25
Earnings per share
Earnings per share, basic₹8.77₹26.44
Earnings per share, diluted₹8.76₹26.40

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Q1 FY27

Entero Healthcare reported consolidated revenue growth of 38.2% year-on-year to Rs 1,940 crore for Q1 FY27, with EBITDA margin reaching 5% for the quarter. Management said organic revenue growth was 17.8% on a reported basis, ahead of the underlying pharmaceutical market growth of 13.8%, while inorganic growth came entirely from calendarization of prior-year acquisitions with no new acquisitions completed during the quarter. Management also discussed the composition of margin expansion, non-controlling interest treatment, working capital days, and return ratios for the quarter.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 57 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Consumer Discretionary › Consumer Services › Pharmacy Retail

Classification as published by BSE.

Companies also in Pharmacy Retail, in alphabetical order

All 2 companies in Pharmacy Retail

Page generated from filings held to 23 Sept 2026.